Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
RMD Open
|
April 20, 2021
The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis
Matthew Turk, Kieran Murray, Yousef Alammari, et al.
The American Journal of Pathology
|
August 13, 2013
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity
Jason P McMorrow, Daniel Crean, Martina Gogarty, et al.
Annals of the Rheumatic Diseases
|
December 23, 2006
Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis
Helena Marzo-Ortega, Dennis McGonagle, Laura A Rhodes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2015
C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis
Munitta Muthana, Sarah Hawtree, Adam Wilshaw, et al.
Arthritis and Rheumatism
|
June 8, 2012
Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes
Viviana Marzaioli, Jason P McMorrow, Hannes Angerer, et al.
Arthritis and Rheumatism
|
January 26, 2012
Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription
Kimberlee S Mix, Kevin McMahon, Jason P McMorrow, et al.
The Journal of Rheumatology
|
August 13, 2009
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers
Barry Bresnihan, Eliza Pontifex, Rogier M Thurlings, et al.
Rheumatology (Oxford, England)
|
November 18, 2022
HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients
Sara Martínez-Ramos, Carlos Rafael-Vidal, Beatriz Malvar-Fernández, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 24, 2015
Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database
Emilia Gvozdenović, Ron Wolterbeek, Cornelia F Allaart, et al.
Arthritis and Rheumatism
|
April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
RMD Open
|
April 20, 2021
The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis
Matthew Turk, Kieran Murray, Yousef Alammari, et al.
The American Journal of Pathology
|
August 13, 2013
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity
Jason P McMorrow, Daniel Crean, Martina Gogarty, et al.
Annals of the Rheumatic Diseases
|
December 23, 2006
Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis
Helena Marzo-Ortega, Dennis McGonagle, Laura A Rhodes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2015
C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis
Munitta Muthana, Sarah Hawtree, Adam Wilshaw, et al.
Arthritis and Rheumatism
|
June 8, 2012
Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes
Viviana Marzaioli, Jason P McMorrow, Hannes Angerer, et al.
Arthritis and Rheumatism
|
January 26, 2012
Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription
Kimberlee S Mix, Kevin McMahon, Jason P McMorrow, et al.
The Journal of Rheumatology
|
August 13, 2009
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers
Barry Bresnihan, Eliza Pontifex, Rogier M Thurlings, et al.
Rheumatology (Oxford, England)
|
November 18, 2022
HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients
Sara Martínez-Ramos, Carlos Rafael-Vidal, Beatriz Malvar-Fernández, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 24, 2015
Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database
Emilia Gvozdenović, Ron Wolterbeek, Cornelia F Allaart, et al.
Arthritis and Rheumatism
|
April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Page
of 4